PTCT
PTC THERAPEUTICS, INC.
Key Financials
Operating Income
$866.9M
↑ 386.5%
Net Income
$682.6M
↑ 287.9%
EPS (Diluted)
$7.78
↑ 264.5%
Total Assets
$2.9B
↑ 70.0%
Revenue
$1.7B
↑ 114.5%
Total Liabilities
$3.1B
↑ 10.7%
Shareholders' Equity
$-205313000.00
↑ 81.3%
Cash & Equivalents
$984.6M
↑ 26.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PTCT |
| Company Name | PTC THERAPEUTICS, INC. |
| CIK | 1070081 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 9082227000 |